Managed Healthcare Executive May 16, 2024
The study found that the average annual costs for individuals with Chronic lymphocytic leukemia (CLL) were significantly higher compared to a matched non-CLL cohort.
Chronic lymphocytic leukemia (CLL) is a type of blood cancer and the most common type of leukemia. It mainly affects older adults; the average age at CLL diagnosis is 70 years. In 2023, more than 18,000 people were diagnosed with CLL and nearly 4,500 people died from it, according to American Cancer Society estimates.
Survival rates for blood cancers have improved due to the availability of better treatments, including targeted therapies like tyrosine kinase inhibitors (TKIs). For instance, the five-year survival rate for a different type of leukemia, chronic myeloid leukemia, has gone up from 22%...
Today's Sponsors
Today's Sponsor